Page last updated: 2024-10-25

cimetidine and Alveolar Bone Atrophy

cimetidine has been researched along with Alveolar Bone Atrophy in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Longhini, R1
Aparecida de Oliveira, P1
Sasso-Cerri, E1
Cerri, PS1

Other Studies

1 other study available for cimetidine and Alveolar Bone Atrophy

ArticleYear
Cimetidine reduces alveolar bone loss in induced periodontitis in rat molars.
    Journal of periodontology, 2014, Volume: 85, Issue:8

    Topics: Acid Phosphatase; Alveolar Bone Loss; Alveolar Process; Animals; Cimetidine; Coloring Agents; Connec

2014